Back

Evaluation of diagnostic accuracy of extreme cardiovascular risk definitions in acute coronary syndrome patients

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Secondary prevention Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Alessandro Maloberti

ASST Great Metropolitan Niguarda, Milan (Italy)

10 More presentations in this session

Presentation thumbnail
Discussant - Secondary prevention
Presentation thumbnail
Trajectories of adherence to secondary prevention pharmacotherapy after coronary angiography: a retrospective population-based study
Doctor L. Heitmann (Reykjavik, IS)
Abstract Slides Video
Presentation thumbnail
CVDPREVENT- the national audit of cardiovascular disease prevention in primary care in England driving quality improvement
Mrs L. Corteville (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany
Doctor V. Oettinger (Freiburg, DE)
Abstract
Presentation thumbnail
Low utilization of GLP-1RAs and SGLT2i in high-risk cardiovascular patients with diabetes: nationwide insights from myocardial Infarction and stroke survivors
Professor M. Vrablik (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Secondary prevention

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry
thumbnail
Congress Presentation
Underestimation of cardiovascular risk in four European countries: results from the prospective, non-interventional MILOS study
thumbnail
Congress Presentation
Tailoring cardiovascular risk assesment: Vascular ultrasound as an emerging and accesible tool

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources